Checkpoint Therapeutics Inc (CKPT)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

2 GANSEVOORT STREET NEW YORK, NY 10014

Checkpoint Therapeutics, Inc. operates as an immuno-oncology biopharmaceutical company. The Company focuses on the acquisition, development, and commercialization of immune-enhanced combination treatments for patients with solid tumor cancers. Checkpoint Therapeutics develops novel immuno-oncology and checkpoint inhibitor antibodies.

Data as of 2021-05-08 11:50:13 -0400
Market Cap181.131 Million Shares Outstanding72.164 Million Avg 30-day Volume912.938 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-4.74 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.39431 52-week High/Low5.38 / 1.56 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from CKPT instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 1 -100.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 64 55 16.36% 18 (1.08%) 14 (0.87%) 28.57%
13F shares: 12.042 Million 12.81 Million -5.99% 2.594 Million 2.633 Million -1.46%
% Ownership 19.7787 21.0397 -5.99% 4.2608 4.324 -1.46%
New Positions: 17 11 54.55% 6 4 50.0%
Increased Positions 29 20 45.0% 6 5 20.0%
Closed Positions 8 3 166.67% 2 2 0.0%
Reduced Positions 8 11 -27.27% 3 2 50.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CKPT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CKPT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

OLIVIERO JAMES F III CEO, PRESIDENT AND DIRECTOR

  • Officer
  • Director
3,153,210 2021-02-04 2

GRAY WILLIAM GARRETT CHIEF FINANCIAL OFFICER

  • Officer
482,170 2021-02-04 4

BOILEN SCOTT

  • Director
134,502 2020-06-05 1

WEISS MICHAEL S

  • Director
62,280 2020-06-05 1

ROSENWALD LINDSAY A MD

  • Director
262,280 2020-06-05 1

SALZMAN BARRY M

  • Director
112,280 2020-06-05 1

HERSKOWITZ NEIL

  • Director
112,280 2020-06-05 1

BECHON CHRISTIAN

  • Director
85,832 2020-06-05 1

FORTRESS BIOTECH, INC.

  • 10% Owner
2,702,705 2017-03-17 0

HORIN DAVID J INTERIM CFO

  • Officer
0 2016-09-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 22:15:03 UTC -0.8359 0.8859 200000
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 21:45:03 UTC -0.8359 0.8859 200000
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 21:15:03 UTC -0.8359 0.8859 200000
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 20:45:03 UTC -0.8359 0.8859 200000
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 20:15:04 UTC -0.8359 0.8859 200000
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 19:45:02 UTC -0.8359 0.8859 200000
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 19:15:03 UTC -0.8359 0.8859 200000
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 18:45:03 UTC -0.8359 0.8859 200000
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 18:15:03 UTC -0.8359 0.8859 200000
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 17:45:03 UTC -0.8359 0.8859 200000
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 17:15:03 UTC -0.8359 0.8859 200000
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 16:45:03 UTC -0.834 0.884 200000
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 16:15:03 UTC -0.834 0.884 200000
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 15:45:03 UTC -0.834 0.884 200000
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 15:15:02 UTC -0.834 0.884 200000
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 14:45:04 UTC -0.8222 0.8722 200000
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 14:15:03 UTC -0.8222 0.8722 200000
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 13:45:03 UTC -0.8222 0.8722 200000
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 13:15:03 UTC -0.8222 0.8722 200000
CHECKPOINT THERAPEUTICS INC CKPT 2021-05-14 12:45:03 UTC -0.8222 0.8722 200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments